期刊
VACCINE
卷 33, 期 16, 页码 1981-1986出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2015.02.040
关键词
Plasmodium falciparum; Pfs48/45; GLURP; Transmission blocking; SMFA
资金
- Seventh Framework Program Theme Health [2009-2.3.2-5, 242079]
- Danish Council for Strategic research [13127]
- Proof of Concept funding, Ministry of Science, Innovation and Higher Education, Denmark
The sexual stage Pfs48/45 antigen is a well-established lead candidate for a transmission blocking (TB) vaccine because of its critical role in parasite fertilization. We have recently produced the carboxyterminal 10C-fragment of Pfs48/45 containing three known epitopes for TB antibodies as a chimera with the N-terminal region of GLURP (R0). The resulting fusion protein elicited high titer TB antibodies in rodents. To increase the relatively low yield of correctly folded Pfs48/45 we have generated a series of novel chimera truncating the 10C-fragments to 6 cysteine residues containing sub-units (6C). All constructs harbor the major epitope I for TB antibodies. One of these sub-units (R0.6Cc), produced high yields of correctly folded conformers, which could be purified by a simple 2-step procedure. Purified R0.6Cc was stable and elicits high titer TB antibodies in rats. The yield, purity and stability of R0.6Cc allows for further clinical development. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据